Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone Co-induction with Vedolizumab in Crohn's Disease
NCT02324699Phase 4Terminated
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Apr 2016
- Primary completion
- Feb 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of prednisone in Crohn's disease, sponsored by Icahn School of Medicine at Mount Sinai. Started Apr 2016; status: terminated.
02
Drugs
prednisone
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT02324699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02324699.